Aldosterone Regulates Rapid Trafficking of Epithelial Sodium Channel Subunits in Renal Cortical Collecting Duct Cells Via Protein Kinase D Activation
Overview
Molecular Biology
Affiliations
Aldosterone elicits rapid physiological responses in target tissues such as the distal nephron through the stimulation of cell signaling cascades. We identified protein kinase D (PKD1) as an early signaling response to aldosterone treatment in the M1-cortical collecting duct (M1-CCD) cell line. PKD1 activation was blocked by the PKC inhibitor chelerythrine chloride and by rottlerin, a specific inhibitor of PKCdelta. The activation of PKCdelta and PKCepsilon coincided with PKD1 activation and while a complex was formed between PKD1 and PKCepsilon after aldosterone treatment, there was a concurrent reduction in PKD1 association with PKCdelta. A stable PKD1 knockdown M1-CCD-derrived clone was developed in which PKD1 expression was 90% suppressed by gene silencing with a PKD1-specific siRNA. The effect of aldosterone treatment on the subcellular distribution of enhanced cyan fluorescent protein (eCFP)-tagged epithelial sodium channel (ENaC) subunits in wild type (WT) and PKD1 suppressed cells was examined using confocal microscopy. In an untreated confluent monolayer of M1-CCD cells, alpha, beta, and gamma ENaC subunits were evenly distributed throughout the cytoplasm of WT and PKD1-suppressed cells. After 2 min treatment, aldosterone stimulated the localization of each of the ENaC subunits to discrete regions within the cytoplasm of WT cells. The translocation of eCFP-ENaC subunits in WT cells was inhibited by rottlerin and the mineralocorticoid receptor (MR) antagonist spironolactone. No subcellular translocation of eCFP-ENaC subunits was observed in PKD1-suppressed cells treated with aldosterone. These data demonstrate the involvement of a novel MR/PKCdelta /PKD1 signaling cascade in the earliest ENaC subunit intracellular trafficking events that follow aldosterone treatment.
Aldosterone: Renal Action and Physiological Effects.
Johnston J, Welch A, Cain B, Sayeski P, Gumz M, Wingo C Compr Physiol. 2023; 13(2):4409-4491.
PMID: 36994769 PMC: 11472823. DOI: 10.1002/cphy.c190043.
Badran M, Bender S, Gozal D Int J Mol Sci. 2023; 24(3).
PMID: 36768567 PMC: 9916750. DOI: 10.3390/ijms24032245.
Martinez-Lemus L, Aroor A, Ramirez-Perez F, Jia G, Habibi J, Demarco V Front Physiol. 2017; 8:456.
PMID: 28713285 PMC: 5492307. DOI: 10.3389/fphys.2017.00456.
Aldosterone Upregulates Transient Receptor Potential Melastatin 7 (TRPM7).
Valinsky W, Jolly A, Miquel P, Touyz R, Shrier A J Biol Chem. 2016; 291(38):20163-72.
PMID: 27466368 PMC: 5025699. DOI: 10.1074/jbc.M116.735175.
Pojoga L, Yao T, Opsasnick L, Siddiqui W, Reslan O, Adler G J Pharmacol Exp Ther. 2015; 355(1):32-47.
PMID: 26183312 PMC: 4576669. DOI: 10.1124/jpet.115.226043.